RARE
Ultragenyx Pharm (RARE)
NASDAQ
$15.17+$0.42 (+2.83%)
Price as of Oct 02, 2026 5:34 PM EDT
  • $1.5B
    Market Cap
  • -52.27%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 36
Valuation
RARE
vs History
vs S&P 500
Profitability
-1
Growth
-1
Low Earnings Volatility
3

Momentum Score

Score: 52
Valuation
RARE
vs History
vs S&P 500
3-Month Momentum
-22.70%
12-Month Momentum
-13.94%
3-Month Risk Adjusted Momentum
-128.28%
12-Month Risk Adjusted Momentum
-21.11%

True Yield

N/A
Valuation
RARE
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 44
Valuation
RARE
vs History
vs S&P 500
Ohlson's O-Score
6